Extramural vascular invasion detected by contrast-enhanced multiple-row detectors computed tomography (ceMDCT) as a predictor of synchronous metastases in colon cancer

By -

 

Executive Summary

This briefing document synthesizes research investigating the efficacy of contrast-enhanced multiple-row detectors computed tomography (ceMDCT) in detecting extramural vascular invasion (EMVI) and its role in predicting synchronous metastases in patients with colon cancer.

Critical Takeaways:

  • Predictive Power: ctEMVI (CT-detected EMVI) is a potent preoperative indicator for synchronous metastases. Patients with positive ctEMVI are 7.3 times more likely to present with synchronous metastases than those without.

  • Key Risk Factors: Multivariate analysis identifies positive ctEMVI (Odds Ratio 4.654) and an extramural tumor depth (ctEMD) greater than 5 mm (Odds Ratio 2.654) as the most significant preoperative radiological factors.

  • Incidence and Correlation: ctEMVI was observed in 39.8% of the study cohort and demonstrated significant associations with tumor depth, lymph node status (both preoperative and postoperative), and pathological tumor status.

  • Clinical Application: The presence of ctEMVI on preoperative scans should trigger more aggressive imaging strategies, such as FDG-PET/CT or liver-specific MRI, to detect potentially misdiagnosed or small-scale metastases.

Overview of Extramural Vascular Invasion (EMVI)

EMVI is histologically defined as the presence of tumor cells beyond the muscularis propria within blood vessels. In colorectal cancer, the invasion of blood or lymph vessels is a critical step in the development of distant metastases. While EMVI has been extensively studied via MRI in rectal cancer, this research highlights its diagnostic significance in colon cancer through the use of ceMDCT.

ctEMVI Scoring Criteria

The research utilizes a scoring system (0–3) based on morphological features visible on MDCT to define EMVI status:

CT Score

CT Status

Morphological Features on CT

EMVI Status

0

Definite No

No tumor extension beyond colon wall or no adjacent vessels involved.

Negative

1

Suspicious No

Stranding in proximity of vessels but no tumor density in vessels.

Negative

2

Suspicious Yes

Tumor density in adjacent vessels; vessel expansion by tumor.

Positive

3

Definite Yes

Tumor density in adjacent vessels; irregular vessel contour.

Positive


Analysis of Synchronous Metastases

Synchronous metastases (SM) are defined as distant metastases detected at the initial diagnosis or within three months of curative surgery. In the study cohort of 241 patients, SM were confirmed in 19.5% (47/241) of cases.

Distribution of Metastatic Sites

The primary sites for synchronous metastases identified in the study include:

  • Hepatic (Liver): 46.8% (22/47)

  • Peritoneal: 17.0% (8/47)

  • Lung: 10.6% (5/47)

  • Multi-organ involvement: 19.1% (9/47) involved two organs; 4.2% (2/47) involved liver, lung, and peritoneum.

Statistical Correlation with ctEMVI

The incidence of synchronous metastases was significantly higher in patients with positive ctEMVI:

  • Positive ctEMVI Cohort: 37.5% (36/96) had synchronous metastases.

  • Negative ctEMVI Cohort: 7.6% (11/145) had synchronous metastases.

Preoperative and Postoperative Predictive Factors

The study identifies specific radiological and pathological markers that correlate with the presence of synchronous metastases.

Preoperative Radiological Factors (Multivariate Analysis)

Factor

Odds Ratio (OR)

95% Confidence Interval (CI)

P-Value

Positive ctEMVI

4.654

1.987–10.898

< 0.001

ctEMD ≥ 5 mm

2.654

1.116–6.309

0.027

Note: Preoperative CT-detected lymph node status (ctN) was not demonstrated as a significant independent predictor in the multivariable model, likely due to the lower accuracy of MDCT in N-staging compared to pathology.

Postoperative Pathological Factors

Postoperative analysis confirmed that pathological lymph node status (pN) is strongly associated with synchronous metastases:

  • pN1: OR 4.866

  • pN2: OR 15.135

Associations Between ctEMVI and Other Parameters

The presence of ctEMVI is not an isolated finding but correlates heavily with the severity of the primary tumor and nodal involvement.

  • Tumor Depth (ctEMD): ctEMVI presence varied significantly based on extramural tumor depth (chi^2 = 66.557, P < 0.001).

  • Lymph Node Status: Significant associations were found between ctEMVI and both CT-detected lymph nodes (ctN) and pathological lymph nodes (pN).

  • Pathological Tumor Status (pT): ctEMVI was more common in higher tumor stages (T4a and T4b).

  • Non-Significant Covariates: Factors such as age, sex, tumor location (right vs. left colon), and tumor differentiation did not show a statistically significant relationship with the presence of ctEMVI.

Discussion and Clinical Implications

Diagnostic Accuracy and Limitations

While MDCT is the standard modality for evaluating colon cancer due to short scan times and 3D reconstruction capabilities, its soft-tissue resolution can limit the detection of small metastases (≤ 1 cm). The study notes that:

  • Staging liver MRI is often reported to have a sensitivity of 91.0–97.0% for identifying liver metastases, superior to standard MDCT.

  • FDG PET/CT and MRI are not currently routine first-line examinations for all colorectal cancer patients.

Recommendations for Precision Treatment

The research suggests that ctEMVI can serve as a "high-risk" filter. Identifying ctEMVI preoperatively allows clinicians to:

  1. Select High-Risk Patients: Prioritize patients for advanced imaging (MRI/PET) who might otherwise have small metastases missed by routine MDCT.

  2. Optimize Resources: Save medical resources by only applying expensive imaging modalities to those with radiological indicators of vascular invasion.

  3. Refine Surgical Planning: Anticipate more aggressive disease states in patients with ctEMVI and tumor depths exceeding 5 mm.

Conclusion

MDCT-detected EMVI is a critical preoperative radiological factor for predicting synchronous metastases in colon cancer. The study concludes that "before operation, patients with positive EMVI on MDCT may need a more aggressive imaging strategy... to screen potential synchronous metastases."